A detailed history of Efg Capital International Corp. transactions in Exact Sciences Corp stock. As of the latest transaction made, Efg Capital International Corp. holds 3,053 shares of EXAS stock, worth $179,913. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,053
Holding current value
$179,913
% of portfolio
0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 02, 2023

BUY
$62.68 - $95.05 $191,362 - $290,187
3,053 New
3,053 $287 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.4B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Efg Capital International Corp. Portfolio

Follow Efg Capital International Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Capital International Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Capital International Corp. with notifications on news.